Correction to: Bone Marrow Transplantation https://doi.org/10.1038/s41409-023-02068-3, published online 08 August 2023
Following the publication of this article, the authors would like to add an additional reference as below to add context on the original discovery of PLX-R18's proposed therapeutic capabilities:
16. Gaberman E, Pinzur L, Levdansky L, Tsirlin M, Nete~ N, Aberman Z, et al. Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Cells. PLoS One. 2013;8(6):e66549
The remaining references have been relabelled accordingly.
The authors also noted the omission of ‘et al’ in the below reference:
17. Pinzur L, Akyuez L, Levdansky L, Blumenfeld M, Volinsky E, Aberman Z, et al. Rescue from Lethal Acute Radiation Syndrome (ARS) with Severe Weight Loss by Secretome of Intramuscularly Injected Human Placental Stromal Cells. Journal of Cachexia Sarcopania and Muscle. 2018;9:1079-1092
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
McGuirk, J.P., Metheny, L., Pineiro, L. et al. Correction: Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study. Bone Marrow Transplant 60, 425 (2025). https://doi.org/10.1038/s41409-024-02469-y
Published:
Issue date:
DOI: https://doi.org/10.1038/s41409-024-02469-y
